Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).
Future Oncol. 2023 Dec;19(38):2505-2516. doi: 10.2217/fon-2023-0486. Epub 2023 Sep 6.
Future Oncol. 2023.
PMID: 37671641
Free article.
Review.
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study.
Psyrri A, Fayette J, Harrington K, Gillison M, Ahn MJ, Takahashi S, Weiss J, Machiels JP, Baxi S, Vasilyev A, Karpenko A, Dvorkin M, Hsieh CY, Thungappa SC, Segura PP, Vynnychenko I, Haddad R, Kasper S, Mauz PS, Baker V, He P, Evans B, Wildsmith S, Olsson RF, Yovine A, Kurland JF, Morsli N, Seiwert TY; KESTREL Investigators.
Psyrri A, et al. Among authors: thungappa sc.
Ann Oncol. 2023 Mar;34(3):262-274. doi: 10.1016/j.annonc.2022.12.008. Epub 2022 Dec 16.
Ann Oncol. 2023.
PMID: 36535565
Free article.
Clinical Trial.
Item in Clipboard
Landscape of clinically actionable mutations in breast cancer 'A cohort study'.
Ghosh M, Naik R, Lingaraju SM, Susheela SP, Patil S, Srinivasachar GK, Thungappa SC, Murugan K, Jayappa SB, Bhattacharjee S, Rao N, Bandimegal M, Krishnappa R, Poppareddy SH, Raghavendrachar KC, Shivakumar Y, Nagesh S, Kodandapani R, Rajan A, Bahadur U, Agrawal P, Ramaswamy V, Nanjaiah TB, Kunigal S, Katragadda S, Manjunath A, Ram A, Ajaikumar BS.
Ghosh M, et al. Among authors: thungappa sc.
Transl Oncol. 2021 Jan;14(1):100877. doi: 10.1016/j.tranon.2020.100877. Epub 2020 Oct 21.
Transl Oncol. 2021.
PMID: 33099186
Free PMC article.
Item in Clipboard
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
Sangro B, Chan SL, Kelley RK, Lau G, Kudo M, Sukeepaisarnjaroen W, Yarchoan M, De Toni EN, Furuse J, Kang YK, Galle PR, Rimassa L, Heurgué A, Tam VC, Van Dao T, Thungappa SC, Breder V, Ostapenko Y, Reig M, Makowsky M, Paskow MJ, Gupta C, Kurland JF, Negro A, Abou-Alfa GK; HIMALAYA investigators.
Sangro B, et al. Among authors: thungappa sc.
Ann Oncol. 2024 May;35(5):448-457. doi: 10.1016/j.annonc.2024.02.005. Epub 2024 Feb 19.
Ann Oncol. 2024.
PMID: 38382875
Free article.
Clinical Trial.
Item in Clipboard
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.
Abou-Alfa GK, Lau G, Kudo M, Chan SL, Kelley RK, Furuse J, Sukeepaisarnjaroen W, Kang YK, Van Dao T, De Toni EN, Rimassa L, Breder V, Vasilyev A, Heurgué A, Tam VC, Mody K, Thungappa SC, Ostapenko Y, Yau T, Azevedo S, Varela M, Cheng AL, Qin S, Galle PR, Ali S, Marcovitz M, Makowsky M, He P, Kurland JF, Negro A, Sangro B.
Abou-Alfa GK, et al. Among authors: thungappa sc.
NEJM Evid. 2022 Aug;1(8):EVIDoa2100070. doi: 10.1056/EVIDoa2100070. Epub 2022 Jun 6.
NEJM Evid. 2022.
PMID: 38319892
Item in Clipboard
Translational relevance of baseline peripheral blood biomarkers to assess the efficacy of anti-programmed cell death 1 use in solid malignancies.
Varayathu H, Sarathy V, Thomas BE, Mufti SS, Sangi L, Thungappa SC, Tripathi P, Naik R.
Varayathu H, et al. Among authors: thungappa sc.
J Cancer Res Ther. 2021 Jan-Mar;17(1):114-121. doi: 10.4103/jcrt.JCRT_910_20.
J Cancer Res Ther. 2021.
PMID: 33723141
Free article.
Item in Clipboard
The future of lung cancer therapy: Striding beyond conventional EGFR and ALK treatments.
Iyer S, Prajapati R, Ramesh A, Basavalingegowda M, Todur S, Kavishvar S, Vijaykumar R, Naik R, Kulkarni P, Bhatt AD, Maniar V, Maka V, Thungappa SC, Singhal M, Ranade A, Shafi G.
Iyer S, et al. Among authors: thungappa sc.
Mol Clin Oncol. 2019 Apr;10(4):469-475. doi: 10.3892/mco.2019.1811. Epub 2019 Feb 20.
Mol Clin Oncol. 2019.
PMID: 30931120
Free PMC article.
Item in Clipboard
Cite
Cite